广告投放

“泛冠状病毒”疫苗:RNA聚合酶成为疫苗靶点

Resistance to COVID-19 infection has been observed in health care workers and has been attributed to the presence of memory T cells that target the RNA polymerase in the RTC (replication transcription complex), thereby preventing infection. This makes RNA polymerase an important target for making a pan-coronavirus vaccine that will be effective against SARS-CoV-2 and its other variants of concern (VoC’s), but also against the family of Coronaviruses in general. 

Covid-19 流感大流行 is now almost 2 years old and has caused havoc among the world by disrupting world economy and halting the normal way of living. Millions have died and many more have been infected with the disease leading to high levels of morbidity. However, there have been instances where people have cleared the infection from the system so quickly that they didn’t test positive for the 病毒 or developed antibodies against it. This resistance has been attributed to the memory T cells-possibly those that are produced after exposure of the human system to such 病毒

Swalding 等人最近在《自然》杂志上发表的一项研究中,来自 60 名高风险的医护人员的血液样本 Covid-19 due to their exposure, were examined and found out to be negative for the 病毒 and for the antibodies against the virus1. It is hypothesised that pre-existing memory T-cells, with cross-protective potential against SARS-CoV-2, expand in vivo to provide rapid viral clearance, thus aborting infection. These T cells are directed against the RNA聚合酶 在 RTC(复制转录复合物)中,而不是病毒的任何其他结构蛋白。 这些记忆 T 细胞可能是通过接触其他呼吸道或相关冠状病毒在医护人员中产生的,尽管没有直接证据表明这一点。 也有可能是其他环境因素导致了这些 T 细胞的产生。 此外,这些血清阴性个体还表现出 IFI27 的增加,这是一种指示 SARS-CoV-2 感染流产的蛋白质。 IFI27 是一种干扰素 α 诱导蛋白,在暴露于包括 SARS-CoV-2 在内的多种呼吸道病毒时会过度表达。 这也可能是导致个体病毒清除、预先暴露于其他呼吸道病毒、然后感染 SARS-CoV-2 的原因。 

The fact that the memory T cells are directed against the RNA polymerase (being the most conserved among the human 冠状病毒 that cause common cold and SARS-CoV-2), makes this enzyme an important target to develop a pan-冠状病毒 vaccine that would not only be directed against SARS-CoV-2 and its other variants of concern (VoC’s) that have evolved as a result of mutations in the spike protein leading to more severe disease, but also against the family of Coronaviruses in general. 

*** 

Sumber:  

Swadling, L., Diniz, MO, Schmidt, NM 等。 预先存在的聚合酶特异性 T 细胞在流产的血清阴性 SARS-CoV-2 中扩增。 自然 (2021)。 https://doi.org/10.1038/s41586-021-04186-8 

***

拉杰夫·索尼
拉杰夫·索尼https://www.RajeevSoni.org/
Rajeev Soni 博士 (ORCID ID : 0000-0001-7126-5864) 拥有博士学位。 拥有英国剑桥大学生物技术学士学位,并在斯克里普斯研究所、诺华、诺维信、Ranbaxy、Biocon、Biomerieux 等全球多家机构和跨国公司工作 25 年,并担任美国海军研究实验室的首席研究员在药物发现、分子诊断、蛋白质表达、生物制造和业务发展方面。

订阅电邮通讯

将通过所有最新新闻,优惠和特别公告进行更新。

最热门文章

Vogue 中的 COVID-19 疫苗类型:会不会有什么问题?

在医学实践中,人们通常更喜欢时间...

内布拉星盘和“宇宙之吻”太空任务

Nebra Sky Disk 启发了...的徽标

CoViNet:全球冠状病毒实验室新网络 

一个新的全球冠状病毒实验室网络,CoViNet,...
- 广告 -
94,488风扇喜欢
47,677产品粉丝关注
1,772产品粉丝关注
30认购订阅